DexCom, a developer of continuous glucose monitoring systems, has collaborated with Google-turned-Alphabet's Life Sciences division to develop new products that will be smaller and less expensive than current monitoring systems.
The announcement of the collaboration comes right on the heels of the newly formed Alphabet, the parent holding company that Google cofounders Larry Page and Sergey Brin formed to better manage and organize their digital empire.
Life Sciences now operates under Alphabet's domain instead of Google's. The new partnership with DexCom focuses on developing a miniature diabetes sensor, no larger than the size of a bandage, which will monitor blood sugar levels constantly instead of through repeated finger pricks, according to a Forbes report.
This is the second diabetes-related project Life Sciences has taken on. The company is already working with pharmaceutical giant Novartis to develop a smart contact lens that measures blood sugar levels through tear fluid on the eyeball.
More articles on health IT:
15 thoughts on interoperability from healthcare leaders
IBM to acquire Merge for $1B; Epic's Judy Faulkner among the richest people in tech; Cerner's revenue climbs while profit falls — 7 health IT key notes
Judy Faulkner named to Forbes' 'Richest People in Tech' list